BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 29102279)

  • 21. Biological Characterization of the Effects of Filtration on the Xoft Axxent® Electronic Brachytherapy Source for Cervical Cancer Applications.
    Walter AE; Cosper PF; Nickel KP; Ramesh S; Khan AU; DeWerd LA; Kimple RJ
    Radiat Res; 2023 May; 199(5):429-438. PubMed ID: 37014873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA damage by radiation as a function of electron energy and interaction at the atomic level with Monte Carlo simulation.
    Lamghari Y; Lu H; Bentourkia M
    Z Med Phys; 2023 Nov; 33(4):489-498. PubMed ID: 35973908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Needle-free cervical cancer treatment using helical multishield intracavitary rotating shield brachytherapy with the
    Hopfensperger KM; Adams Q; Kim Y; Wu X; Xu W; Patwardhan K; Thammavong B; Caster J; Flynn RT
    Med Phys; 2020 Jun; 47(5):2061-2071. PubMed ID: 32073669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of Rotating Shield Brachytherapy for Prostate Cancer Dose Escalation and Urethral Sparing.
    Adams Q; Hopfensperger KM; Kim Y; Wu X; Xu W; Shukla H; McGee J; Caster JM; Flynn RT
    Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1543-1550. PubMed ID: 30092333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can intermediate-energy sources lead to elevated bone doses for prostate and head & neck high-dose-rate brachytherapy?
    Famulari G; Alfieri J; Duclos M; Vuong T; Enger SA
    Brachytherapy; 2020; 19(2):255-263. PubMed ID: 31964601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MONTE CARLO-BASED INVESTIGATION OF MICRODOSIMETRIC DISTRIBUTION OF HIGH ENERGY BRACHYTHERAPY SOURCES.
    Chattaraj A; Selvam TP; Datta D
    Radiat Prot Dosimetry; 2019 Dec; 187(1):115-128. PubMed ID: 31165891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Approaches to calculating AAPM TG-43 brachytherapy dosimetry parameters for 137Cs, 125I, 192Ir, 103Pd, and 169Yb sources.
    Melhus CS; Rivard MJ
    Med Phys; 2006 Jun; 33(6):1729-37. PubMed ID: 16872080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calculated microdosimetric characteristics of 125I and 103Pd brachytherapy seeds at different depths in water.
    Wuu CS; Chen J
    Radiat Prot Dosimetry; 2006; 122(1-4):506-8. PubMed ID: 17189276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maximum RBE change in
    Nusrat H; Karim-Picco S; Pang G; Paudel M; Sarfehnia A
    Biomed Phys Eng Express; 2020 Jan; 6(1):015021. PubMed ID: 33438609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microdosimetric Evaluation of Current and Alternative Brachytherapy Sources-A Geant4-DNA Simulation Study.
    Famulari G; Pater P; Enger SA
    Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):270-277. PubMed ID: 29102279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Which RBE for iodine 125 in clinical applications?
    Scalliet P; Wambersie A
    Radiother Oncol; 1987 Jul; 9(3):221-30. PubMed ID: 3306808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The inverse square law: A basic principle in brachytherapy.
    Marcié S; Gerard JP; Dejean C; Feuillade J; Gautier M; Montagné L; Fuentes C; Hannoun-Levi JM
    Cancer Radiother; 2022 Nov; 26(8):1075-1077. PubMed ID: 35843781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of the Geant4-DNA Simulation Toolkit for Radiobiological Applications at the Cellular and DNA Level.
    Kyriakou I; Sakata D; Tran HN; Perrot Y; Shin WG; Lampe N; Zein S; Bordage MC; Guatelli S; Villagrasa C; Emfietzoglou D; Incerti S
    Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008196
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.